A Twenty-years' Experience in Pituitary Disease.

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

1600 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-03-10

Study Completion Date

2028-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Pituitary tumors represent a heterogeneous group of neoplasms by histotype. The pituitary adenomas are the most frequent heteroformation, among those affecting the pituitary gland, followed by meningiomas, craniopharyngiomas, germosomes and tumours secondary, such as metastases and lymphomas. Since these conditions are considered rare, the data epidemiology and prognosis to predict the natural history of these diseases can not be considered conclusive. Pituitary adenomas are a useful model for epidemiology in the study of pathology pituitary. Over the past 20 years, several attempts have been made to identify unique prognostic factors, which predict the outcome of these pathologies, but without To arrive at a definitive classification. The purpose of this study aims to collect clinical, biochemical, morphological and pathological data on the retrospective and prospective cohort of over 1600 patients undergoing neurosurgical removal of pituitary tumors in the last 20 years, to develop a prognostic classification.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Epidemiology of Pituitary Tumours: Prevalence of Associated Neoplasia

NCT03973450

Pituitary Tumor Endocrine Neoplasia Hyperparathyroidism +2 more

UNKNOWN

Endocrine Outcome of Surgery for Pituitary Adenoma

NCT03515603

Pituitary Adenoma

TERMINATED NA

Predictive Factors of Recurrence of Non Functioning Pituitary Adenomas : a Retrospective Study of 220 Patients in the Reims University Hospital, France

NCT02803697

Pituitary Adenomas

COMPLETED

Pituitary Tumor Surveillance: Pathogenic Correlation

NCT00599092

Pituitary Tumor

RECRUITING

Predictive Factors for Survival in Aggressive Meningiomas

NCT05793034

Meningioma Meningioma Atypical Anaplastic Meningioma

RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pituitary Adenoma Pituitary Cancer Pituitary Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

OTHER

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients with pituitary tumors

Patients with pituitary tumors, underwent surgical resection

Frequency of disease recurrence

Intervention Type OTHER

To collect data of pituitary disease recurrence

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Frequency of disease recurrence

To collect data of pituitary disease recurrence

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients underwent surgery for pituitary tumors;
* pathology diagnosis of pituitary tumors;
* patients older then 18 years at diagnosis of pituitary tumors;
* 2 years follow-up;